Skip to main content
. 2022 Feb 23;13:765446. doi: 10.3389/fphar.2022.765446

TABLE 2.

Incidence of depression and anxiety in diabetes patients with/without GLP1-RA use.

Outcome variables Non-GLP1-RA vs. GLP1-RA user
Non-GLP1-RA user GLP1-RA user
Any depression or anxiety
 Follow-up years 1.97 ± 1.53 2.62 ± 1.51
 Event 857 157
 Person-year 91546 23090
 Incidence Rate 9.36 6.80
 Crude HR (95% CI) ref. 0.72 (0.60, 0.85)***
 Model 1 ref. 0.73 (0.61, 0.86)***
 Model 2 ref. 0.73 (0.62, 0.87)***
 Model 3 ref. 0.80 (0.67, 0.95)**
Anxiety
 Follow-up years 1.93 ± 1.52 2.39 ± 1.48
 Event 656 116
 Person-year 91838 23158
 Incidence Rate 7.14 5.01
 Crude HR (95% CI) ref. 0.70 (0.57, 0.85)***
 Model 1 ref. 0.70 (0.58, 0.86)***
 Model 2 ref. 0.71 (0.58, 0.86)***
 Model 3 ref. 0.78 (0.64, 0.95)*
Depression
 Follow-up years 2.08 ± 1.57 2.92 ± 1.60
 Event 308 68
 Person-year 92594.49 23304.4
 Incidence Rate 3.32 2.91
 Crude HR (95% CI) ref. 0.85 (0.66, 1.11)
 Model 1 ref. 0.85 (0.66, 1.11)
 Model 2 ref. 0.87 (0.67, 1.14)
 Model 3 ref. 0.94 (0.72, 1.23)

*p < 0.05, **p < 0.01, ***p < 0.001.

Incidence rate, per 1,000 person-years; HR, hazard ratio; CI, confidence interval.

Demographic factors include age, gender, urbanization level and enrollee category.

1:4 propensity score matching.

Model 1: Adjust for demographic factors.

Model 2: Adjust for model 1 + comorbidity.

Model 3: Adjust for model 2 + medication.